Digital Health Startups

Emoha is an Indian senior care brand providing at-home holistic care for individuals aged 55+, including geriatric care, 24/7 emergency support, health monitoring, hospital accompaniment, and engagement activities. It offers membership plans serving seniors and their families across 200 cities in India.

2 investors

emol develops a mobile app that delivers self-help cognitive behavioral therapy (CBT) through an AI character named "Roku," aimed at preventing and treating mental illnesses such as depression and anxiety. The company targets consumers seeking accessible mental healthcare and is working toward a therapeutic app for treating psychiatric conditions.

2 investors

Emovi Inc commercializes KneeKG, a regulatory-cleared clinical assessment tool that measures knee movement patterns to evaluate functional deficiencies and aid in orthopaedic decision-making for pain management and surgical planning.

2 investors

Empallo provides telehealth cardiac care led by cardiac specialists, offering treatment plans, medication management, and at-home testing options such as Holter monitoring and sleep studies. It serves patients seeking cardiovascular care remotely from home.

2 investors

eMurmur is a software platform that enables remote and in-person auscultation (listening to body sounds) using digital stethoscopes, allowing healthcare providers to screen, monitor, diagnose, and consult on heart, lung, and bowel health. The platform operates via a web portal and mobile app, supporting live streaming, specialist consultation, and integration with electronic health records and telemedicine systems.

2 investors

Endogene is a biotech company focused on uterine biology, developing tools to improve the understanding, diagnosis, and treatment of uterine diseases.

2 investors

Endor Health is building a modern, automated platform to help people living with diabetes access care and supplies. The company aims to simplify the fragmented experience of managing diabetes for the diabetes community.

2 investors

Enhanced develops a scientific platform that combines sports performance analysis with human potential optimization. The company serves athletes and individuals seeking evidence-based approaches to safely enhance performance.

2 investors

Bloom was a mental health app, acquired by Spring Health in February 2024, with the app scheduled to discontinue on February 23, 2025.

2 investors

Enlace Health provides a value-based care operating system, proprietary technology platform, and consulting services to help healthcare payors and providers manage specialty value-based care programs. It serves organizations navigating value-based healthcare transformation.

2 investors

Ennoble Care provides personalized in-home primary care, hospice, and palliative care services to patients. The company delivers compassionate healthcare focused on individualized patient support and well-being.

2 investors

Ensweet offers a cardiac telerehabilitation solution that lets patients follow their rehabilitation program at home while being monitored remotely by a multidisciplinary care team, via a web interface for clinicians and a mobile app for patients. Aimed at cardiovascular disease patients in France, its Ensweet Cardio product is a CE-marked medical device for hybrid and at-home cardiac rehabilitation.

2 investors

Enthea provides access to mental health treatment, including psychedelic-assisted therapy, positioned as a safe and affordable benefit for employers and healthcare consumers. The company serves corporate wellness programs, insurance plans, and health systems seeking to expand mental health treatment options.

2 investors

Entia develops at-home blood monitoring solutions for healthcare providers and patients. The company aims to reduce treatment burden and healthcare system disruption by integrating monitoring technology into daily life.

2 investors

EnVue Health is a digital health platform designed to increase health equity and access to personalized, inclusive care for patients and providers. The platform focuses on bridging gaps between patients and providers by addressing systemic biases and healthcare inequities.

2 investors

Enzyre develops a handheld diagnostic device that performs multiple blood coagulation assays in parallel to identify bleeding causes at the point of care. The device aims to enable rapid therapy adjustment for patients and reduce healthcare costs by bringing laboratory testing capabilities to clinical settings.

2 investors

Eolas operates a platform that delivers targeted, evidence-based medical content to healthcare professionals at the point of clinical decision-making. The platform enables pharmaceutical companies, medical device manufacturers, and healthcare organizations to provide relevant educational materials and treatment guidelines to clinicians based on specialty and clinical needs.

2 investors

EPICS Therapeutics develops RNA epigenetics-based cancer treatments, focusing on METTL3 inhibitors for cancers including non-small cell lung cancer, pancreatic cancer, ovarian cancer, and colorectal cancer where existing therapies are insufficient.

2 investors

Epigene Labs develops AI-powered tools for analyzing genomic data and precision oncology research, serving biopharmaceutical companies and cancer researchers. The company builds software platforms and conducts translational research to support the development of personalized cancer therapies.

2 investors

A company bringing together expertise in genetics, pathology, medicine, and bioinformatics to develop data science and AI solutions in the healthcare field.

2 investors

Epikast provides AI-powered tools for medical science liaisons and field teams to analyze clinical interactions with physicians and patients, and to access synthesized scientific information in their disease areas. The company serves pharmaceutical and life sciences companies seeking to enhance communication and relationship management with healthcare professionals.

2 investors

Epistemic AI combines AI agents with a team of scientists, engineers, and business leaders to produce evidence-based analysis for biopharma and life-science decisions. Its scientists shape and review the AI-driven analysis over connected evidence to support consequential industry decisions.

2 investors

Epitomee develops ingestible therapeutic devices and platforms that deliver targeted therapies along the gastrointestinal tract to manage metabolic diseases, obesity, and deliver biologics. The company combines mechanical and ingestible morphology platforms with therapeutic agents to achieve specific localization with limited side effects.

2 investors

Epsilon partners radiologists with advanced technology to address the radiology shortage in the US and improve diagnostic accuracy and speed. The company combines human expertise with AI to reduce delays in medical imaging, which accounts for 75% of medical decisions.

2 investors